Investigating the incidence of cardiovascular in patients with ercutaneous coronary interventionin bandar abbas shahid mohammadi hospital
,1,* Parsa rahmanzadeh
,2 Sadeq shiri
,3 Hossein farshidi
1. Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2. Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
4. Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
pci(percutaneous coronary intervention) is one of the most common mode of re vascularization. so according to the importance and progress of pci in curing coronary artery disease(cad) and concering the complications of pci in predicting the clinical outcomes, it is necessary to observe the risk factors and current variables.
In a prospective descriptive-analytic study, that patients with cad under pci in shahid mohammadi bandar abbas hospital in in 1395 also full access to selected for this study. was provided research datas by demographic information and specific_relevant clinical information after one year follow up , overall of patients data were redigistered in the check list of proposal. the data was processed by spss-v19 . research data analyzed by distribution indicators ; tables, mean, standard deviation got analyzed.
In 192 patients who were studied, the high age(%12.6) and bleeding in during the pci(%4.1) was associated with recurrence of mi during the one year after pci, as well as died tue old cases (%2.1), diabetic (%2.1), and cases with bleeding during pci (%2.1) . it was found that there is significant relationship between « need for recurrence of cardiovascular caucus» and «non_pharmavologic stent , pci and bleeding in during the pci ( p<0.001) also the patients with more involved vessels.
It seams the disorders of pci, be possible to prophylaxis for the major cardiovascular diseases, so according to the results it is recommended the patients with cad and pci follow up for long tome for clinical prophylaxis plan.
Dyslipidemia, repeated cabg, kidney chronic failure, pc i, cad, congestive heart failure, mi